4.7/5 - (67 votes)

A recent study by Japanese scientists highlights key immune mechanisms that help centenarians, particularly those aged 110 and above, resist cancer and deadly infections.

CD4 lymphocytes

Building on earlier findings that showed elevated levels of a specific immune cell -known as CD4 cytotoxic T lymphocytes (CTL CD4) -among supercentenarians, the researchers aimed to pinpoint the role these cells play in fending off various health threats as a person ages.

To achieve this, the team recruited a unique group of participants: eight individuals aged 70 to 99, ten aged 100 to 109, and another ten who were 110 years old or older. “It may seem like a small group, but the latest national census indicates there are only about 150 supercentenarians in Japan,” explained Kousuke Hashimoto from Osaka University, who led the research published in the journal Cell Reports.

Blood analyses revealed a progressive increase in the percentage of CD4 CTLs: 4 percent among the youngest group, rising to 10 percent for the second, and reaching 17 percent for those over 110. Remarkably, these immune cells showed no signs of “exhaustion,” maintaining their ability to target cancerous or virus-infected cells effectively.

Increasing threats

According to Hashimoto, as we age, the threats to our health become more pronounced, prompting an increase in the production of these CD4 CTLs. “It is quite remarkable that even after living for over a century, the immune system continues to adapt,” he noted. “If we can understand the mechanisms involved, we may be able to enhance immune responses in others.”

Read also:  Innovative approach to rhinoplasty offers exciting possibilities

This study aligns with research on MarĂ­a Branyas Morera, the oldest woman in the world until her death in 2024 at the age of 117 years and 168 days. “She overcame numerous infections and was known to be the oldest person to contract Covid-19 while remaining asymptomatic,” explained Manel Esteller from the Sant Pau Research Institute in Barcelona.

It was also found that Branyas Morera carried several genetic variants associated with a significantly reduced risk of cardiovascular issues, diabetes, and neurodegenerative conditions.